Oral 2-methyl-thieno-benzodiazepine formulation

Details Oral 2-methyl-thieno-benzodiazepine formulation Oral 2-methyl-thieno-benzodiazepine formulation

2007-06-12

2007-06-12

Woodward, Michael P. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S400000, C424S464000, C424S465000, C424S474000, C424S475000, C424S479000

Reexamination Certificate

active

10887017

ABSTRACT:
The invention provides a pharmaceutically elegant solid oral formulation of olanzapine and a process for making such formulation.

REFERENCES:
patent: 4115568 (1978-09-01), Chakrabarti et al.
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 5457101 (1995-10-01), Greenwood et al.
patent: 5696115 (1997-12-01), Rasmussen
patent: 5919485 (1999-07-01), Cochran et al.
patent: 6780433 (2004-08-01), Cochran et al.
patent: 0 496 437 (1992-07-01), None
patent: 0 582 368 (1994-02-01), None
patent: 0733367 (1996-09-01), None
Farmacia Practica of Remington, Second Spanish Edition, UTEHA, “Coating of tablets, capsules and pills”, Mexico, (1965), pp. 505, 506 and 510.
Helman, Jose: Coating of Tablets and Related Dosage Forsm, Theoretical and Practical Pharmacotechnics, vol. VI Nov. 1982, CIA. Editorial Continental S.A. DE C.V. Mexico.
Hercules, Technical Information, Apr. 1993, “Using pure KLUCEL EF hydroxypropylcellulose to aqueous film coat tablets”, pp. 1-2.
Wade A et al: Handbook of Pharmaceutical Excipients, Second Edition, 1994, pp. 355-361.
Problem Solver and Reference Manual, Presented by the Pharmaceutical Industry, FMC Corporation, 1984, pp. 1-9.

Affiliated with

Also associated with

Rating

Oral 2-methyl-thieno-benzodiazepine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral 2-methyl-thieno-benzodiazepine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral 2-methyl-thieno-benzodiazepine formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3859619